|
|
???tair.name??? >
???browser.page.title.author???
|
"liu chen hua"???jsp.browse.items-by-author.description???
Showing items 16-40 of 153 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T15:18:59Z |
Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy
|
陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; Liang, Cheng-Chao; HUNG-CHIH YANG; Liu, Chen-Hua; CHUN-JEN LIU; Chung, Chen-Shuan; PEI-JER CHEN; CHEN-HUA LIU; Lin, Cheng-Kuan; Chen, Hsiao-Jan; Su, Tung-Hung; DING-SHINN CHEN; TUNG-HUNG SU; Yang, Hung-Chih; JIA-HORNG KAO; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Liang, Cheng-Chao;Liu, Chen-Hua;Chung, Chen-Shuan;Lin, Cheng-Kuan;Su, Tung-Hung;Yang, Hung-Chih;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liang, C.-C. and Liu, C.-H. and Chung, C.-S. and Lin, C.-K. and Su, T.-H. and Yang, H.-C. and Liu, C.-J. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H. |
| 臺大學術典藏 |
2018-09-10T15:18:58Z |
Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers
|
TUNG-HUNG SU; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Verbree, Femke Carolien; Su, Tung-Hung; Wang, Chia-Chi; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Chen, Chi-Ling;Yang, Wan-Ting;Tsai, Cheng-Shiue;Kuo, Stephanie Fang-Tzu;Verbree, Femke Carolien;Su, Tung-Hung;Wang, Chia-Chi;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Tseng, T.-C. and Liu, C.-J. and Yang, H.-C. and Chen, C.-L. and Yang, W.-T. and Tsai, C.-S. and Kuo, S.F.-T. and Verbree, F.C. and Su, T.-H. and Wang, C.-C. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; HUNG-CHIH YANG; Tseng, Tai-Chung; Liu, Chun-Jen; CHUN-JEN LIU; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; Chen, Chi-Ling; Yang, Wan-Ting; DING-SHINN CHEN; Tsai, Cheng-Shiue |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, T.-H. and Shiau, C.-W. and Jao, P. and Liu, C.-H. and Liu, C.-J. and Tai, W.-T. and Jeng, Y.-M. and Yang, H.-C. and Tseng, T.-C. and Huang, H.-P. and Cheng, H.-R. and Chen, P.-J. and Chen, K.-F. and Kao, J.-H. and Chen, D.-S.; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; HUNG-CHIH YANG; Su, Tung-Hung; HSIANG-PO HUANG; Shiau, Chung-Wai; Jao, Ping; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; YUNG-MING JENG; Liu, Chun-Jen; CHEN-HUA LIU; Tai, Wei-Tien; DING-SHINN CHEN; Cheng, Wern-Cherng; Jeng, Yung-Ming; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Huang, Jee-Fu;Lin, Jou-Wei;Liang, Cheng-Chao;Yang, Sheng-Shun;Lin, Chih-Lin;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Kao, Jia-Horng;Yu, Ming-Lung; Liu, C.-H. and Huang, C.-F. and Liu, C.-J. and Dai, C.-Y. and Huang, J.-F. and Lin, J.-W. and Liang, C.-C. and Yang, S.-S. and Lin, C.-L. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Kao, J.-H. and Yu, M.-L.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;林昭維; Wu, Cho-Kai; Liu, Chen-Hua; HUNG-CHIH YANG; CHUN-JEN LIU; Su, Mao-Yuan; Huang, Chung-Feng; PEI-JER CHEN; Lee, Jen-Kuang; Liu, Chun-Jen; Dai, Chia-Yen; Chiang, Fu-Tien; CHEN-HUA LIU; Hwang, Juey-Jen; Huang, Jee-Fu; DING-SHINN CHEN; Lin, Jiunn-Lee; TUNG-HUNG SU; Lin, Jou-Wei; JIA-HORNG KAO; Chen, Jin-Jer; Liang, Cheng-Chao; Yang, Sheng-Shun; Liu, Fu-Tong; Lin, Chih-Lin; Tsai, Chia-Ti; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; ??????; ?L?T??; ?????; ??Z??; ?d????; ???礯; ?????? |
| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial
|
DING-SHINN CHEN; Hung, Peir-Haur; Tsai, Hung-Bin; JIA-HORNG KAO; Lee, Chih-Yuan; Chen, Shih-I; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; TUNG-HUNG SU; Liu, Chen-Hua;Liu, Chun-Jen;Huang, Chung-Feng;Lin, Jou-Wei;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Lee, Chih-Yuan;Chen, Shih-I;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, C.-H. and Liu, C.-J. and Huang, C.-F. and Lin, J.-W. and Dai, C.-Y. and Liang, C.-C. and Huang, J.-F. and Hung, P.-H. and Tsai, H.-B. and Tsai, M.-K. and Lee, C.-Y. and Chen, S.-I. and Yang, S.-S. and Su, T.-H. and Yang, H.-C. and Chen, P.-J. and Chen, D.-S. and Chuang, W.-L. and Yu, M.-L. and Kao, J.-H.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;李志元;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; HUNG-CHIH YANG; Liu, Chen-Hua; Liu, Chun-Jen; MENG-KUN TSAI; Huang, Chung-Feng; CHUN-JEN LIU; PEI-JER CHEN; Lin, Jou-Wei; HUNG-BIN TSAI; Dai, Chia-Yen; Liang, Cheng-Chao; CHEN-HUA LIU; Huang, Jee-Fu |
| 臺大學術典藏 |
2018-09-10T15:18:40Z |
Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker in Predicting Pathological Response to Neoadjuvant Chemoradiation
|
陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維; Hsu, Feng-Ming; Liu, Chen-Hua; YIH-LEONG CHANG; Cheng, Jason Chia-Hsien; Huang, Chung-Feng; ERIC YAO-YU CHUANG; Chang, Yih-Leong; JANG-MING LEE; Liu, Chun-Jen; Dai, Chia-Yen; Lee, Jang-Ming; Huang, Jee-Fu; Koong, Albert C.; Lin, Jou-Wei; Chuang, Eric Y.; Liang, Cheng-Chao; Yang, Sheng-Shun; Lin, Chih-Lin; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Chang, Yih-Leong;Lee, Jang-Ming;Koong, Albert C.;Chuang, Eric Y.; Hsu, F.-M. and Cheng, J.C.-H. and Chang, Y.-L. and Lee, J.-M. and Koong, A.C. and Chuang, E.Y.; 張逸良;成佳憲;李章銘;許峰銘; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T15:02:21Z |
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma
|
Ho, W.-L. and Chou, C.-H. and Jeng, Y.-M. and Lu, M.-Y. and Yang, Y.-L. and Jou, S.-T. and Lin, D.-T. and Chang, H.-H. and Lin, K.-H. and Hsu, W.-M. and Huang, M.-C.; Ho, Wan-Ling;Chou, Chih-Hsing;Jeng, Yung-Ming;Lu, Meng-Yao;Yang, Yung-Li;Jou, Shiann-Tarng;Lin, Dong-Tsamn;Chang, Hsiu-Hao;Lin, Kai-Hsin;Hsu, Wen-Ming;Huang, Min-Chuan; 林東燦;許文明;鄭永銘;周獻堂;黃敏銓;盧孟佑;張修豪;林凱信;楊永立; Ho, Wan-Ling; Liu, Chen-Hua; HSIU-HAO CHANG; Kao, Jia-Horng; Chou, Chih-Hsing; KAI-HSIN LIN; Jeng, Yung-Ming; Lu, Meng-Yao; Yang, Yung-Li; Jou, Shiann-Tarng; Lin, Dong-Tsamn; Chang, Hsiu-Hao; Lin, Kai-Hsin; Hsu, Wen-Ming; Huang, Min-Chuan; �B���~; ���ŧ� |
| 臺大學術典藏 |
2018-09-10T14:59:24Z |
Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B
|
Lin, C.-L. and Liu, C.-H. and Wang, C.-C. and Liang, C.-C. and Su, T.-H. and Liu, C.-J. and Kao, J.-H.; Lin, Chih-Lin;Liu, Chen-Hua;Wang, Chia-Chi;Liang, Cheng-Chao;Su, Tung-Hung;Liu, Chun-Jen;Kao, Jia-Horng; 劉振驊;高嘉宏;蘇東弘;劉俊人; Lin, Shin-Yi; Lin, Chih-Lin; CHUN-JEN LIU; CHEN-HUA LIU; Tang, Sung-Chun; Liu, Chen-Hua; Liu, Chen-Hua; Wang, Chia-Chi; JIA-HORNG KAO; Tsai, Li-Kai; Liang, Cheng-Chao; Yeh, Shin-Joe; Su, Tung-Hung; Su, Tung-Hung; Shen, Li-Jiuan; Liu, Chun-Jen; Liu, Chun-Jen; Wu, Fe-Lin Lin; Kao, Jia-Horng; Jeng, Jiann-Shing; Kao, Jia-Horng; ?G???; ?L?z??; ???O??; ?????; ???|?g; ?H?R?S |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously
|
Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Chen, Ting-Chih;Tseng, Tai-Chung;Liu, Chen-Hua;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; Cheng, Huei-Ru;Kao, Jia-Horng;Wu, Hui-Lin;Chen, Ting-Chih;Tseng, Tai-Chung;Liu, Chen-Hua;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen; Cheng, H.-R. and Kao, J.-H. and Wu, H.-L. and Chen, T.-C. and Tseng, T.-C. and Liu, C.-H. and Su, T.-H. and Chen, P.-J. and Chen, D.-S. and Liu, C.-J.; 陳定信;劉振驊;高嘉宏;吳慧琳;蘇東弘;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;吳慧琳;蘇東弘;劉俊人;陳培哲; Cheng, Huei-Ru; CHUN-JEN LIU; PEI-JER CHEN; Kao, Jia-Horng; CHEN-HUA LIU; Wu, Hui-Lin; DING-SHINN CHEN; Chen, Ting-Chih; Tseng, Tai-Chung; TUNG-HUNG SU; Liu, Chen-Hua; JIA-HORNG KAO; Su, Tung-Hung; Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters
|
Liu, Chen-Hua; Liu, Chen-Hua; Lin, L. -Y.; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng; 林亮宇; 陳保中; 林俊立; 江福田; 吳卓鍇; 黃瑞仁; 蔡佳醍; 陳祈玲; Tseng, T.-C. and Liu, C.-J. and Yang, W.-T. and Chen, C.-L. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Wan-Ting;Chen, Chi-Ling;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲;陳祈玲; Wu, C. -K.; Tseng, Tai-Chung; HUNG-CHIH YANG; Liu, Chun-Jen; Yang, Y. -H.; Liu, Chun-Jen; CHUN-JEN LIU; Yang, Wan-Ting; Yang, Wan-Ting; PEI-JER CHEN; Lin, T. -T.; CHEN-HUA LIU; Tsai, C. -T.; Chen, Chi-Ling; Yang, Hung-Chih; DING-SHINN CHEN; Hwang, J. -J.; Yang, Hung-Chih; Su, Tung-Hung; TUNG-HUNG SU; Lin, J. -L.; Su, Tung-Hung; Wang, Chia-Chi; Chen, P. -C.; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Chiang, F. -T. |
| 臺大學術典藏 |
2018-09-10T14:50:10Z |
Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications
|
Wu, Hui-Lin;Kao, Jia-Horng;Chen, Ting-Chih;Wu, Wen-Hsuan;Liu, Chen-Hua;Su, Tung-Hung;Yang, Hung-Chih;Chen, Ding-Shinn;Chen, Pei-Jer;Liu, Chun-Jen; Wu, H.-L. and Kao, J.-H. and Chen, T.-C. and Wu, W.-H. and Liu, C.-H. and Su, T.-H. and Yang, H.-C. and Chen, D.-S. and Chen, P.-J. and Liu, C.-J.; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳培哲; Wu, Hui-Lin; HUNG-CHIH YANG; Kao, Jia-Horng; CHUN-JEN LIU; Kao, Jia-Horng; PEI-JER CHEN; Chen, Ting-Chih; Chang, Julia Yu-Fong; CHEN-HUA LIU; Wu, Wen-Hsuan; Liu, Chen-Hua; TUNG-HUNG SU; Liu, Chen-Hua; Su, Tung-Hung; DING-SHINN CHEN; Su, Tung-Hung; JIA-HORNG KAO; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Ding-Shinn; Chen, Pei-Jer; Chen, Pei-Jer; Liu, Chun-Jen; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:50:07Z |
Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin.
|
Chen, Ming-Yao;Liu, Chen-Hua;Chen, Ting-Chih;Su, Tung-Hung;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng;Liu, Chun-Jen; 陳定信;高嘉宏;劉俊人;陳培哲; Chen, Ming-Yao; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Chen, Ting-Chih; Su, Tung-Hung; TUNG-HUNG SU; Chang, Wen-Hsiung; Chen, Pei-Jer; DING-SHINN CHEN; Chen, Ding-Shinn; JIA-HORNG KAO; Kao, Jia-Horng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T14:50:07Z |
Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.
|
Liu, Chen-Hua;Kao, Jia-Horng; Liu, Chen-Hua; CHEN-HUA LIU; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:49:16Z |
A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus
|
Lin, Y.-T.; Tsai, J.-C.; Chen, H.-J.; Hung, W.-C.; Hsueh, P.-R.; Teng, L.-J.; Liu, Chen-Hua; Tsai, Jui-Chang; Liu, Chun-Jen; Hsueh, Po-Ren; Su, Tung-Hung; Yang, Hung-Chih; Teng, Lee-Jene; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳培哲;劉俊人;蘇東弘;楊宏志;高嘉宏;劉振驊;Kao, Jia-Horng;Chen, Ding-Shinn;Chen, Pei-Jer;Teng, Lee-Jene;Yang, Hung-Chih;Teng, Lee-Jene;Hsueh, Po-Ren;Su, Tung-Hung;Hsueh, Po-Ren;Hung, Wei-Chun;Hung, Wei-Chun;Lin, Chih-Lin;LEE-JENE TENG;Chen, Hsiao-Jan;Liu, Chun-Jen;JUI-CHANG TSAI;Liang, Cheng-Chao;Tsai, Jui-Chang;Tsai, Jui-Chang;Lin, Yu-Tzu;Lin, Yu-Tzu;Liu, Chen-Hua;PO-REN HSUEH;Teng, L.-J.;Hsueh, P.-R.;Hung, W.-C.;Chen, H.-J.;Tsai, J.-C.;Lin, Y.-T.;Kao, Jia-Horng;Chen, Ding-Shinn;Chen, Pei-Jer;Teng, Lee-Jene;Yang, Hung-Chih;Teng, Lee-Jene;Hsueh, Po-Ren;Su, Tung-Hung;Hsueh, Po-Ren;Hung, Wei-Chun;Hung, Wei-Chun;Lin, Chih-Lin;LEE-JENE TENG;Chen, Hsiao-Jan;Liu, Chun-Jen;JUI-CHANG TSAI;Liang, Cheng-Chao;Tsai, Jui-Chang;Tsai, Jui-Chang;Lin, Yu-Tzu;Lin, Yu-Tzu;Liu, Chen-Hua;PO-REN HSUEH |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype
|
Huang, Chung-Feng;Yu, Ming-Lung;Kao, Jia-Horng;Tseng, Tai-Chung;Yeh, Ming-Lun;Huang, Jee-Fu;Dai, Chia-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Wang, Liang-Yen;Juo, Suh-Hang Hank;Chuang, Wan-Long;Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Yu, Ming-Lung; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng; Tseng, Tai-Chung; Tseng, Tai-Chung; Yeh, Ming-Lun; Yeh, Ming-Lun; Huang, Jee-Fu; Dai, Chia-Yen; Lin, Zu-Yau; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chuang, Wan-Long; Chuang, Wan-Long; Liu, Chen-Hua; Liu, Chen-Hua |
| 臺大學術典藏 |
2018-09-10T09:49:22Z |
Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection
|
Su, T.-H., Liu, C.-J., Tseng, T.-C., Liu, C.-H., Yang, H.-C., Chen, C.-L., Chen, P.-J., Kao, J.-H., Chen, D.-S.; Su, Tung-Hung;Liu, Chun-Jen;Tseng, Tai-Chung;Liu, Chen-Hua;Yang, Hung-Chih;Chen, Chi-Ling;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chun-Jen; Liu, Chun-Jen; PEI-JER CHEN; CHEN-HUA LIU; Tseng, Tai-Chung; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; TUNG-HUNG SU; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Chi-Ling; JIA-HORNG KAO; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:47:27Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Chen, Hung-Chia;Liu, Chen-Hua;Jeng, Jenher;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Hsu, Shih-Jer; CHEN-HUA LIU; Chen, Hung-Chia; Chen, Hung-Chia; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; Jeng, Jenher; JIA-HORNG KAO; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:24Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, T.-H. and Liu, C.-H. and Liu, C.-J. and Chen, C.-L. and Ting, T.-T. and Tseng, T.-C. and Chen, P.-J. and Kao, J.-H. and Chen, D.-S.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chen-Hua; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Chi-Ling; TUNG-HUNG SU; Ting, Te-Tien; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Hsu, Cheng-An;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; CHUN-JEN LIU; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; Wang, Chia-Chi; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
|
Dai, Chia-Yen; Dai, Chia-Yen; Liang, Cheng-Chao; Huang, Jee-Fu; Hung, Peir-Haur; Hung, Peir-Haur; Tsai, Hung-Bin; Tsai, Hung-Bin; Tsai, Meng-Kun; Chen, Shih-I; Lin, Jou-Wei; Yang, Sheng-Shun; Su, Tung-Hung; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Yu, Ming-Lung; Kao, Jia-Horng; 陳定信; Liu, Chen-Hua;Huang, Chung-Feng;Liu, Chun-Jen;Dai, Chia-Yen;Liang, Cheng-Chao;Huang, Jee-Fu;Hung, Peir-Haur;Tsai, Hung-Bin;Tsai, Meng-Kun;Chen, Shih-I;Lin, Jou-Wei;Yang, Sheng-Shun;Su, Tung-Hung;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Chuang, Wan-Long;Yu, Ming-Lung;Kao, Jia-Horng; Liu, Chun-Jen; 陳定信;劉振驊;高嘉宏;楊宏志;蘇東弘;劉俊人;陳世宜;陳培哲;蔡孟昆;林昭維;蔡宏斌; Liu, Chen-Hua; Liu, Chen-Hua; CHEN-HUA LIU; Huang, Chung-Feng; Huang, Chung-Feng; Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:23:43Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; Liu, Chen-Hua; CHUN-JEN LIU; Liang, Cheng-Chao; Liang, Cheng-Chao; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; DING-SHINN CHEN; Tseng, Tai-Chung; TUNG-HUNG SU; Lin, Chih-Lin; Yang, Sheng-Shun; JIA-HORNG KAO; Su, Tung-Hung; Lin, Jou-Wei; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:23:42Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU |
| 臺大學術典藏 |
2018-09-10T09:14:10Z |
Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Su, Tung-Hung;Yang, Hung-Chih;Wang, Chia-Chi;Chen, Chi-Ling;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;劉俊人 ;陳培哲; CHUN-JEN LIU; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Su, Tung-Hung; CHEN-HUA LIU; TUNG-HUNG SU; Yang, Hung-Chih; DING-SHINN CHEN; Wang, Chia-Chi; Chen, Chi-Ling; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
Showing items 16-40 of 153 (7 Page(s) Totally)
1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
